Cover Image
市場調查報告書

CountryFocus:菲律賓的醫療、規定、醫療費給付制度狀況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

出版商 GlobalData 商品編碼 301408
出版日期 內容資訊 英文 199 Pages
訂單完成後即時交付
價格
Back to Top
CountryFocus:菲律賓的醫療、規定、醫療費給付制度狀況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines
出版日期: 2016年08月16日 內容資訊: 英文 199 Pages
簡介

菲律賓的整體人口2013年達到9920萬人,成為全球第12大的人口大國。出生率高和平均壽命的改善成為人口增加的主要原因。同時,老年人口的增加對政策籌劃者來說成為顧慮事項。菲律賓的醫藥品市場,2013年達到43億美元,然後預計2020年擴大到約80億美元(其間的年複合成長率(CAGR)為9.4%)。

本報告提供菲律賓的醫療相關市場趨勢、醫療費給付制度及其他相關法規、制度相關分析、醫藥品產業、醫療設備產業的整體結構與趨勢、醫療費給付制度與其週邊的保險市場趨勢、醫療法規當局結構和各種法規概要、菲律賓經濟、社會相關宏觀指標(醫療基礎設施等)、今後的市場機會與課題的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 醫藥品、醫療設備市場概要

  • 醫藥品市場
    • 市場概況
    • 醫藥品的進出口
    • 供給途徑
    • 市場分類
    • 主要的疾病領域概要
    • 主要企業
  • 醫療設備市場
    • 市場概況
  • 市場促進、阻礙因素
    • 推動因素
    • 阻礙因素

第4章 市場進入

  • 醫療費給付、保險費付款者狀況
    • 醫療制度概要
    • 醫療費給付的過程
    • 保險業者概要
    • 對於醫療費用支出的患者負擔的比率
    • 醫療服務的價格趨勢
    • 藥價政策
  • 法規環境
    • 法規機關概要
    • 醫藥品銷售認證過程
    • 醫療設備的新產品的認證過程
    • 醫藥品、醫療設備的製造認證過程
    • 醫藥品的進出口
    • 知識產權
    • 臨床實驗相關的法規
    • 醫藥品的廣告相關法規
    • 藥局相關的法規
    • 標籤、包裝相關法規

第5章 該國分析

  • 政治環境
  • 經濟環境
  • 經濟指標
  • 人口統計
  • 醫療基礎設施
    • 醫療設備
    • 醫療相關參數
    • 環境問題
    • 醫護人員
  • 醫療費用支出
    • 概要
    • 醫療費用支出的主要因素
    • 官方/民間部門的佔有率
    • 醫藥品的研究開發(R&D)活動的支出額
  • 產業團體
  • 展示會

第6章 市場機會與課題

  • 市場機會
  • 課題

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC0060CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2015, Philippines population was approximately at 100.9 million. The government of Philippines has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country's future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The Philippines pharmaceutical market is the third-largest pharmaceutical market in the Association of Southeast Asian Nations (ASEAN), after Indonesia and Thailand. The Pharmaceutical market was estimated to be worth $3.4 billion in 2015 and expected to reach $4.1 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.7% over the 2008-2020 period. The medical device market was valued at $400m in 2008 and is expected to reach approximately $600m by 2020, at a projected CAGR of 8.1%.

These positive trends can primarily be attributed to -

  • An increasing elderly population in Philippines, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
  • Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Philippines, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck Co.)
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Philippines healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Philippines healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in Philippines healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of Pharmaceutical and Medical Device Market

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Pharmaceutical Exports and Imports
    • 3.1.3. Supply Channels
    • 3.1.4. Market Segments
    • 3.1.5. Overview of Major Disease Areas
    • 3.1.6. Major Players
  • 3.2. Medical Device Market
    • 3.2.1. Market Overview
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Reimbursement and Payer Landscape
    • 4.1.1. Overview of Healthcare System
    • 4.1.2. Reimbursement Process
    • 4.1.3. Overview of Insurance Providers
    • 4.1.4. Patient Share in Healthcare Spending
    • 4.1.5. Price Trends in the Healthcare Sector
    • 4.1.6. Pricing Policies
  • 4.2. Regulatory Landscape
    • 4.2.1. Overview of Regulatory Agencies
    • 4.2.2. Market Authorization Procedure for Pharmaceutical Products
    • 4.2.3. New Medical Device Approval Process
    • 4.2.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.2.5. Exports and Imports
    • 4.2.6. Intellectual Property Rights
    • 4.2.7. Clinical Trial Regulations
    • 4.2.8. Pharmaceutical Advertising Regulations
    • 4.2.9. Pharmacy Regulations
    • 4.2.10. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. Fiscal Deficit
    • 5.3.9. General Government Gross Debt
    • 5.3.10. External Debt
    • 5.3.11. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.1. Healthcare Facilities
    • 5.5.2. Healthcare Parameters
    • 5.5.3. Environmental Health
    • 5.5.4. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview
    • 5.6.2. Major Components of Healthcare Spending
    • 5.6.3. Share of Public and Private Sector
    • 5.6.4. Spending in Pharmaceutical R&D
  • 5.7. Trade Associations
    • 5.7.1. Pharmaceutical and Healthcare Association of the Philippines
    • 5.7.2. The Philippine Pharmaceutical Manufacturers Association
    • 5.7.3. The Philippine Pharmacist Association
    • 5.7.4. The Philippine Medical Association
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2015
  • Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016-2020
  • Table 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2014
  • Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008
  • Table 5: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
  • Table 6: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016
  • Table 7: GlaxoSmithKline, Global, Major Products Revenue ($m) and Annual Growth (%), 2015
  • Table 8: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016
  • Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
  • Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2014-2018
  • Table 11: Merck & Co., Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
  • Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck & Co., 2016
  • Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2016
  • Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016
  • Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015
  • Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector (%), 2008-2014
  • Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2015
  • Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016-2020
  • Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015
  • Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020
  • Table 21: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2014
  • Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013
  • Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013
  • Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2015
  • Table 25: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2014
  • Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2014
  • Table 27: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2015
  • Table 28: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2015
  • Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014
  • Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015
  • Table 31: Economic Indicators, Philippines, External Debt ($bn), 2008-2015
  • Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012-2013
  • Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013-2014
  • Table 34: Demographics, Philippines, Population (million), 2008-2015
  • Table 35: Demographics, Philippines, Population (million), 2016-2020
  • Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015
  • Table 37: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020
  • Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015
  • Table 39: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020
  • Table 40: Demographics, Philippines, Births (per 1,000 population), 2008-2014
  • Table 41: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014
  • Table 42: Demographics, Philippines, Major Causes of Mortality ('000), 2013
  • Table 43: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015
  • Table 44: Demographics, Philippines, Immunization Rate (%), 2008-2014
  • Table 45: Demographics, Philippines, Major Causes of Male Mortality ('000), 2013
  • Table 46: Demographics, Philippines, Major Causes of Female Mortality ('000), 2013
  • Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014
  • Table 48: Demographics, Philippines, Gender Ratio (M/F), 2008-2014
  • Table 49: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015
  • Table 50: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020
  • Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014
  • Table 52: Demographics, Philippines, Unemployment Rate (%), 2008-2015
  • Table 53: Demographics, Philippines, Major Diseases, Morbidity ('000), 2013
  • Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009
  • Table 55: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014
  • Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014
  • Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009
  • Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009
  • Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014
  • Table 60: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014
  • Table 61: Environmental Health, Philippines, PM2.5 (µg/m³), 2008-2014
  • Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014
  • Table 63: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014
  • Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014
  • Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013
  • Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014
  • Table 67: Healthcare Market, Philippines, Major Trade Fairs, 2016

List of Figures

  • Figure 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2015
  • Figure 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016-2020
  • Figure 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2014
  • Figure 4: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008
  • Figure 5: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008
  • Figure 6: Healthcare Market, Philippines, Drivers and Barriers, 2016
  • Figure 7: Healthcare Market, Philippines, Healthcare System, 2016
  • Figure 8: Healthcare Market, Philippines, Drug Selection Procedure for Philippine National Drug Formulary, 2016
  • Figure 9: Healthcare Market, Philippines, Reimbursement Process, 2016
  • Figure 10: Healthcare Market, Philippines, PhilHealth Milestones, 2016
  • Figure 11: Membership in PhilHealth, Philippines, Sector Share (%), 2016
  • Figure 12: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016
  • Figure 13: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015
  • Figure 14: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector (%), 2008-2014
  • Figure 15: Healthcare Market, Philippines, Food and Drug Administration Structure, 2014
  • Figure 16: Philippines, Healthcare Market, Approval Process of New Drugs and Medical Devices, 2014
  • Figure 17: Healthcare Market, Philippines, Approval Process of Generic Drugs, 2016
  • Figure 18: Healthcare Market, Philippines, Bureau of Health Devices and Technology Structure, 2016
  • Figure 19: Healthcare Market, Philippines, Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, 2016
  • Figure 20: Healthcare Market, Philippines, Patent Approval Process, 2016
  • Figure 21: Healthcare Market, Philippines, Trademark Approval Process, 2016
  • Figure 22: Healthcare Market, Philippines, Clinical Trial Approval Process, 2014
  • Figure 23: Healthcare Market, Philippines, Procedure for Opening a Retail Pharmacy, 2014
  • Figure 24: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 1999-2014
  • Figure 25: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2015
  • Figure 26: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016-2020
  • Figure 27: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015
  • Figure 28: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020
  • Figure 29: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2014
  • Figure 30: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013
  • Figure 31: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013
  • Figure 32: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2015
  • Figure 33: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2014
  • Figure 34: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2014
  • Figure 35: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2015
  • Figure 36: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2015
  • Figure 37: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014
  • Figure 38: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015
  • Figure 39: Economic Indicators, Philippines, External Debt ($bn), 2008-2015
  • Figure 40: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2013-2014
  • Figure 41: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013-2014
  • Figure 42: Demographics, Philippines, Population (million), 2008-2015
  • Figure 43: Demographics, Philippines, Population (million), 2016-2020
  • Figure 44: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015
  • Figure 45: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020
  • Figure 46: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015
  • Figure 47: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020
  • Figure 48: Demographics, Philippines, Births (per 1,000 population), 2008-2014
  • Figure 49: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014
  • Figure 50: Demographics, Philippines, Major Causes of Mortality ('000), 2013
  • Figure 51: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015
  • Figure 52: Demographics, Philippines, Immunization Rate (%), 2008-2014
  • Figure 53: Demographics, Philippines, Major Causes of Male Mortality ('000), 2013
  • Figure 54: Demographics, Philippines, Major Causes of Female Mortality ('000), 2013
  • Figure 55: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014
  • Figure 56: Demographics, Philippines, Gender Ratio (M/F), 2008-2014
  • Figure 57: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015
  • Figure 58: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020
  • Figure 59: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014
  • Figure 60: Demographics, Philippines, Unemployment Rate (%), 2008-2015
  • Figure 61: Demographics, Philippines, Major Diseases, Morbidity ('000), 2013
  • Figure 62: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009
  • Figure 63: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014
  • Figure 64: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014
  • Figure 65: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009
  • Figure 66: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009
  • Figure 67: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014
  • Figure 68: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014
  • Figure 69: Environmental Health, Philippines, PM2.5 (µg/m³), 2008-2014
  • Figure 70: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014
  • Figure 71: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014
  • Figure 72: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014
  • Figure 73: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013
  • Figure 74: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014
  • Figure 75: Healthcare Market, Philippines, Opportunities and Challenges, 2016
Back to Top